TRUVADA (Cardinal Health)
Welcome to the PulseAid listing for the TRUVADA drug offered from Cardinal Health. This Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Cardinal Health |
| NON-PROPRIETARY NAME: | emtricitabine and tenofovir disoproxil fumarate |
| SUBSTANCE NAME: | TENOFOVIR DISOPROXIL FUMARATE; EMTRICITABINE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2004-08-02 |
| END MARKETING DATE: | 0000-00-00 |
TRUVADA HUMAN PRESCRIPTION DRUG Details:
| Item Description | TRUVADA from Cardinal Health |
| LABELER NAME: | Cardinal Health |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 300; 200(mg/1; mg/1) |
| START MARKETING DATE: | 2004-08-02 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 55154-0082_00f1a642-3350-43fb-9efb-2d7bb2555ace |
| PRODUCT NDC: | 55154-0082 |
| APPLICATION NUMBER: | NDA021752 |
Other TENOFOVIR DISOPROXIL FUMARATE; EMTRICITABINE Pharmaceutical Manufacturers / Labelers:
